These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38701513)

  • 1. Cytochrome P450 1B1 is critical in the development of TNF-α, IL-6, and LPS-induced cellular hypertrophy.
    ElKhatib MAW; Gerges SH; Isse FA; El-Kadi AOS
    Can J Physiol Pharmacol; 2024 Jul; 102(7):408-421. PubMed ID: 38701513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol attenuates angiotensin II-induced cellular hypertrophy through the inhibition of CYP1B1 and the cardiotoxic mid-chain HETE metabolites.
    Shoieb SM; El-Kadi AOS
    Mol Cell Biochem; 2020 Aug; 471(1-2):165-176. PubMed ID: 32533462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of cytochrome P450 1B1 and its associated mid-chain hydroxyeicosatetraenoic acid metabolites in the development of cardiac hypertrophy induced by isoproterenol.
    Maayah ZH; Althurwi HN; El-Sherbeni AA; Abdelhamid G; Siraki AG; El-Kadi AO
    Mol Cell Biochem; 2017 May; 429(1-2):151-165. PubMed ID: 28251434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of Angiotensin II-Induced Cellular Hypertrophy by Cannflavin-C: Unveiling the Impact on Cytochrome P450 1B1 and Arachidonic Acid Metabolites.
    Alammari AH; Isse FA; O'Croinin C; Davies NM; El-Kadi AOS
    Drug Metab Dispos; 2024 Jul; 52(8):875-885. PubMed ID: 38839111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluconazole Represses Cytochrome P450 1B1 and Its Associated Arachidonic Acid Metabolites in the Heart and Protects Against Angiotensin II-Induced Cardiac Hypertrophy.
    Alammari AH; Shoieb SM; Maayah ZH; El-Kadi AOS
    J Pharm Sci; 2020 Jul; 109(7):2321-2335. PubMed ID: 32240690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP1B1 inhibition attenuates doxorubicin-induced cardiotoxicity through a mid-chain HETEs-dependent mechanism.
    Maayah ZH; Althurwi HN; Abdelhamid G; Lesyk G; Jurasz P; El-Kadi AO
    Pharmacol Res; 2016 Mar; 105():28-43. PubMed ID: 26772815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 17-(R/S)-hydroxyeicosatetraenoic acid (HETE) induces cardiac hypertrophy through the CYP1B1 in enantioselective manners.
    Isse FA; Alammari AH; El-Sherbeni AA; El-Kadi AOS
    Prostaglandins Other Lipid Mediat; 2023 Oct; 168():106749. PubMed ID: 37244564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 16R-HETE and 16S-HETE alter human cytochrome P450 1B1 enzyme activity probably through an allosteric mechanism.
    Hidayat R; Shoieb SM; Mosa FES; Barakat K; Brocks DR; Isse FA; Gerges SH; El-Kadi AOS
    Mol Cell Biochem; 2024 Jun; 479(6):1379-1390. PubMed ID: 37436655
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Shoieb SM; El-Kadi AOS
    Drug Metab Dispos; 2018 Aug; 46(8):1157-1168. PubMed ID: 29880629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in cytochrome P450-derived arachidonic acid metabolism during pressure overload-induced cardiac hypertrophy.
    El-Sherbeni AA; El-Kadi AO
    Biochem Pharmacol; 2014 Feb; 87(3):456-66. PubMed ID: 24300133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Synthetic Analogues of 19(S/R)-Hydroxyeicosatetraenoic Acid Exhibit Noncompetitive Inhibitory Effect on the Activity of Cytochrome P450 1A1 and 1B1.
    Shoieb SM; Dakarapu R; Falck JR; El-Kadi AOS
    Eur J Drug Metab Pharmacokinet; 2021 Sep; 46(5):613-624. PubMed ID: 34235626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 6-Formylindolo[3,2-b]carbazole Protects Against Angiotensin II-Induced Cellular Hypertrophy through the Induction of Cytochrome P450 1A1 and Its Associated 19(S)-HETE Metabolite In Vitro.
    Alammari AH; Gerges SH; Isse FA; El-Kadi AOS
    Drug Metab Dispos; 2023 Jul; 51(7):833-843. PubMed ID: 37185150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of 19-(
    Shoieb SM; El-Sherbeni AA; El-Kadi AOS
    Drug Metab Dispos; 2019 Feb; 47(2):67-70. PubMed ID: 30420405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450 1A1 and 1B1 promoter CpG island methylation regulates rat liver injury induced by isoniazid.
    Li Y; Li Y; Zheng G; Zhu L; Wang J; Mu S; Ren Q; Feng F
    Mol Med Rep; 2018 Jan; 17(1):753-762. PubMed ID: 29115507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of retinoids and arachidonic acid by human and mouse cytochrome P450 1b1.
    Choudhary D; Jansson I; Stoilov I; Sarfarazi M; Schenkman JB
    Drug Metab Dispos; 2004 Aug; 32(8):840-7. PubMed ID: 15258110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of mid-chain hydroxyeicosatetraenoic acids in the pathogenesis of hypertension and cardiac hypertrophy.
    Maayah ZH; El-Kadi AO
    Arch Toxicol; 2016 Jan; 90(1):119-36. PubMed ID: 26525395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ameliorative Role of Fluconazole Against Abdominal Aortic Constriction-Induced Cardiac Hypertrophy in Rats.
    Shoieb SM; Alammari AH; Levasseur J; Silver H; Dyck JRB; El-Kadi AOS
    J Cardiovasc Pharmacol; 2022 Jun; 79(6):833-845. PubMed ID: 35266922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological and Clinical Implications of TNF-α Promoter and CYP1B1 Gene Variations in Coronary Artery Disease Susceptibility.
    Mir R; Elfaki I; Jha CK; Javid J; Babakr AT; Banu S; Mir MM; Jamwal D; Khullar N; Alzahrani KJ; Chahal SMS
    Cardiovasc Hematol Disord Drug Targets; 2021; 21(4):266-277. PubMed ID: 34939556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol suppresses lipopolysaccharide-mediated activation of osteoclast precursor RAW 264.7 cells by increasing miR-181a-5p expression.
    Xue HY; Liu MW; Yang G
    Int J Immunopathol Pharmacol; 2023; 37():3946320231154995. PubMed ID: 36723677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamate affects the CYP1B1- and CYP2U1-mediated hydroxylation of arachidonic acid metabolism via astrocytic mGlu5 receptor.
    Yu X; Wu J; Hu M; Wu J; Zhu Q; Yang Z; Xie X; Feng YQ; Yue J
    Int J Biochem Cell Biol; 2019 May; 110():111-121. PubMed ID: 30858141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.